Skip navigation

B. After adoption by an institution, the UBMTA may be required to request any transfer transaction by the correct execution of a simple correspondence contract (for which the NIH was also issued). A user is not required to use UBMTA for all transactions and has generally not been able to use it for industry-supported research projects (because these projects usually involve commercial rights). D. Some rules may apply when importing materials into the United States. “The importation of many organic materials into the United States requires USDA approvals.” COGR brochure, Q17. E. Another set of laws concerns the export of materials. Although U.S. export control laws allow most materials to leave the United States without a specific license, special licenses may be required for materials that could be used in chemical or biological weapons, including, for example, human pathogens and toxins.

See COGR brochure, Q20. CRADA was created by the Federal Technology Transfer Act of 1986 (Public Law 99-502). CRADA allows FPL scientists to collaborate with private companies to commercialize the technology on the basis of collaborative research. CRADA grants the cooperative the first right to exclusive licenses for patented inventions discovered or developed under the agreement. To enter a CRADA, the search objective must be consistent with FPL`s mission. CRADA is effective when the cooperating company provides the know-how to develop and market a product, process or service. The company may also cover part of the additional costs of the FPL for the work carried out under the agreement; or the company can provide personnel, equipment or equipment. In some cases, a CRADA cannot include a transfer of credits to FPL. As a co-operator, FPL provides research personnel, laboratory facilities, materials, equipment, accessories and other in-kind services. one.

The supplier appears to want to minimize its potential liability for the transfer and authorization of the use of its unique biological materials. Similarly, the recipient does not want full exposure to the risks that should belong to the offeror, for example. B, the risks associated with the hazardous or toxic properties of the original materials, unless these risks are obvious or the recipient has been properly warned. D. MTAs can also be used by industry to provide, for example, their unique materials to universities for pro-bono research or in ongoing or potentially sponsored research, or to obtain academic materials for their own research and development activities. F. F. “When scientists began to warn that research progress was increasingly hampered by lengthy MTA negotiations, universities and the National Institutes of Health (NIH) took action by joining a standard procedure for transferring equipment for transfers between academic institutions. COGR brochure, id.

The result was the Biological Material Transfer Agreement. See Part II below. B. There are many laws that apply to hazardous substances, including occupational health and safety laws and laws on the storage, transportation, use and disposal of hazardous substances. Ideally, the supplier will inform the recipient of the relevant environmental laws and regulations known to the supplier and, of course, the supplier should provide the recipient with sufficient information about the material so that the recipient can determine the applicable laws himself.